William P. Sheridan
Corporate Officer/Principal at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 30 729 $ as of 2024-03-30
Profile
William P.
Sheridan's current job is as the Chief Development Officer at BioCryst Pharmaceuticals, Inc. His former job was as the Vice President-North American Medical Affairs at Amgen, Inc. He also served as the Head-Bone Marrow Transplant Service at Royal Melbourne Hospital.
Dr. Sheridan holds a doctorate degree from the University of Melbourne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-16 | 6,049 ( 0.00% ) | 30 729 $ | 2024-03-30 |
William P. Sheridan active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-09-14 |
Former positions of William P. Sheridan
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2007-10-31 |
Royal Melbourne Hospital
 Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Training of William P. Sheridan
| University of Melbourne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Health Services |
- Stock Market
- Insiders
- William P. Sheridan
